检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王莹[1] 付权泽 牟琪瑞 刘春英[1] 王淳[1] 高原[1] WANG Ying;FU Quanze;MU Qirui;LIU Chunying;WANG Chun;GAO Yuan(Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China)
机构地区:[1]辽宁中医药大学,沈阳110847
出 处:《中国免疫学杂志》2022年第16期1958-1962,共5页Chinese Journal of Immunology
基 金:国家自然科学基金项目(81403303,81973735,81774184);辽宁省教育厅科研项目(LJKZ0901)。
摘 要:目的:探讨补中益气汤含药血清增强A549细胞对顺铂敏感性的机制是否与GSK-3β介导的Wnt/β-catenin信号通路有关。方法:制备补中益气汤含药血清作用于A549细胞株,随机分为a组(对照血清组)、b组(顺铂组)、c组(补中益气汤组)、d组(补中益气汤含药血清联合顺铂组)。流式细胞术检测细胞凋亡,Western blot检测GSK-3β、p-GSK-3β^(ser9)、p-GSK-3β^(tyr216)、β-catenin、survivin蛋白表达。结果:补中益气汤含药血清联合顺铂可降低p-GSK-3β^(ser9)、β-catenin、survivin蛋白表达,提高晚期细胞凋亡率。结论:抑制GSK-3β介导的Wnt/β-catenin信号通路激活可能是补中益气汤含药血清增强A549细胞对顺铂敏感性的作用机制之一。Objective:To explore whether mechanism of Buzhong Yiqi Decoction containing serum enhancing sensitivity of A549 cells to cisplatin is related to Wnt/β-catenin signaling pathway mediated by GSK-3β.Methods:Buzhong Yiqi Decoction containing serum was prepared and applied to A549 cell line,and randomly divided into:group a(control serum group),group b(cisplatin group),group c(Buzhong Yiqi Decoction group)and group d(Buzhong Yiqi Decoction containing serum combined with cisplatin group).Cell apoptosis was detected by flow cytometry,and expressions of GSK-3β,p-GSK-3β^(ser9),p-GSK-3β^(tyr216),β-catenin and sur⁃vivin were detected by Western blot.Results:Combination of Buzhong Yiqi Decoction containing serum and cisplatin could decrease protein expressions of p-GSK-3β^(ser9),β-catenin and survivin,and increase late apoptosis rate.Conclusion:Inhibiting activation of Wnt/β-catenin signaling pathway mediated by GSK-3βmay be one of mechanisms of Buzhong Yiqi Decoction containing serum enhancing sensitivity of A549 cells to cisplatin.
关 键 词:补中益气汤 A549细胞株 顺铂 GSK-3Β WNT/Β-CATENIN信号通路
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222